更新于：2024-11-01

Qasr El Eyni Hospital

Egypt

更新于：2024-11-01

概览

概览

关联

231

项与 Qasr El Eyni Hospital 相关的临床试验

NCT06627816 / Not yet recruitingN/AIIT

Efficacy of Intravenous Nefopam, Dexmedetomidine, and Meperidine in Preventing Post-Spinal Anesthesia Shivering in Adult Patients Undergoing Lower Abdominal and Lower Limb Surgeries: A Double-Blind Comparative Study

This prospective, randomized, controlled, double-blinded study is designed to evaluate the efficacy of nefopam compared to dexmedetomidine and meperidine for the prevention of postspinal anesthesia shivering while minimizing side effects.

开始日期2024-10-01

申办/合作机构

Qasr El Eyni Hospital

NCT06126055 / Not yet recruitingN/AIIT

EndoBand: Endoscopic Band Ligation for Treating Reflux Disease (GERD)

GERD is a chronic disease the require different treatment modalities; non have proven long term efficacy with concerns about their safety. The use of band ligation in endoscopy appears safe, repeatable with short learning curve. Placing multiple bands at the Z-line can create a fibrous ring in the distal esophagus acting as a barrier against reflux of gastric content.

开始日期2024-09-01

申办/合作机构

Qasr El Eyni Hospital

NCT06558565 / Not yet recruitingN/AIIT

Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia:Randomized Clinical Trial

The goal of this randomized controlled clinical trial is to test the efficacy & safety of stromal vascular fraction in treatment of AGA & compare it to PRP The main questions it aims to answer are:
* efficacy & safety of SVF for treatment of AGA patients
* comparing it to PRP in treatment of AGA Participants will receive a single session of SVF in one half of the scalp & a single session of PRP in the other half.

开始日期2024-08-30

申办/合作机构

Qasr El Eyni Hospital

100 项与 Qasr El Eyni Hospital 相关的临床结果

登录后查看更多信息

0 项与 Qasr El Eyni Hospital 相关的专利（医药）

登录后查看更多信息

项与 Qasr El Eyni Hospital 相关的文献（医药）

2024-04-23·Journal of Chromatographic Science

AGREE and ESA for Greenness Assessment of a Novel Validated RP-HPLC Method for Simultaneous Determination of Aspirin, Warfarin and Clopidogrel in Rat Plasma: Application to Pharmacokinetic Study of the Possible Interaction between the Three Drugs

Article

作者: AlSawy, Norhan S ; ElKady, Ehab F ; Mostafa, Eman A

AbstractThe green profile of the developed method is assessed and compared with previously reported methods. Percutaneous coronary intervention is a procedure where a catheter is utilized to place a stent in order to facilitate opening of the blood vessels in the heart. Triple antithrombotic therapy includes oral anticoagulation as warfarin and dual antiplatelet therapy (composed of aspirin and clopidogrel bisulfate). The aim of the current study was to evaluate the pharmacokinetic parameters of ASP, WAR and CLP and to investigate the possible interaction between the three drugs upon co-administration in rats. A selective and precise RP-HPLC method was developed for the simultaneous determination of ASP, WAR and CLP in rat plasma. Pharmacokinetic study was conducted in rats that received ASP, WAR and CLP as an application of the developed method. From the statistical evaluation of the pharmacokinetic parameters, it was observed that the co-administration of ASP, WAR and CLP significantly increased the ASP and CLP bioavailability in rats. A significant drug–drug interaction was confirmed in the current study. The elevated Cmax of ASP and CLP upon the co-administration of ASP, WAR and CLP may explain the reported bleeding.

2016-05-01·European Journal of Heart Failure1区 · 医学

Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology

1区 · 医学

Article

作者: Taha, Nasser ; Parsonage, William A. ; Irtyuga, Olga ; Johnson, Mark R. ; Thorne, Sara A. ; van Hagen, Iris M. ; Hall, Roger ; Boersma, Eric ; Leśniak‐Sobelga, Agata ; Sorour, Khaled A. ; Maggioni, Aldo P. ; Roos‐Hesselink, Jolien W. ; Escribano Subías, Pilar

AbstractAimsTo validate the modified World Health Organization (mWHO) risk classification in advanced and emerging countries, and to identify additional risk factors for cardiac events during pregnancy.Methods and resultsThe ongoing prospective worldwide Registry Of Pregnancy And Cardiac disease (ROPAC) included 2742 pregnant women (mean age ± standard deviation, 29.2 ± 5.5 years) with established cardiac disease: 1827 from advanced countries and 915 from emerging countries. In patients from advanced countries, congenital heart disease was the most prevalent diagnosis (70%) while in emerging countries valvular heart disease was more common (55%). A cardiac event occurred in 566 patients (20.6%) during pregnancy: 234 (12.8%) in advanced countries and 332 (36.3%) in emerging countries. The mWHO classification had a moderate performance to discriminate between women with and without cardiac events (c‐statistic 0.711 and 95% confidence interval (CI) 0.686–0.735). However, its performance in advanced countries (0.726) was better than in emerging countries (0.633). The best performance was found in patients with acquired heart disease from developed countries (0.712). Pre‐pregnancy signs of heart failure and, in advanced countries, atrial fibrillation and no previous cardiac intervention added prognostic value to the mWHO classification, with a c‐statistic of 0.751 (95% CI 0.715–0.786) in advanced countries and of 0.724 (95% CI 0.691–0.758) in emerging countries.ConclusionThe mWHO risk classification is a useful tool for predicting cardiac events during pregnancy in women with established cardiac disease in advanced countries, but seems less effective in emerging countries. Data on pre‐pregnancy cardiac condition including signs of heart failure and atrial fibrillation, may help to improve preconception counselling in advanced and emerging countries.

2015-12-01·Journal of Endovascular Therapy2区 · 医学

The Ascending Aorta as an Exit Site for a Through-and-Through Wire in TEVAR

2区 · 医学

Article

作者: Mylonas, Spyridon ; Ahmad, Wael ; Brunkwall, Jan ; Sharkawy, Mohamed ; Wippermann, Jens ; Brunkwall, Silke

Purpose: To describe a technique for trans–ascending aorta through-and-through guidewire placement for thoracic endograft advancement and deployment. Case Report: A 55-year-old man presented with a symptomatic pseudoaneurysm of the distal aortic arch after aortic coarctation open repair. He had also undergone mechanical aortic valve replacement. Planned were a left-sided carotid-subclavian bypass and a thoracic endovascular aortic repair with a chimney graft to the left common carotid artery. After carotid-subclavian bypass, efforts to retrograde cannulate the aortic arch and advance the thoracic endograft were unsuccessful. Because of the mechanical heart valve, no transapical approach could be used. Access to the ascending aorta was gained through a midline sternotomy. A through-and-through wire was positioned from the ascending aorta to femoral artery, which provided the required stability for advancement of the thoracic endograft. Six-month computed tomography documented patent endografts and carotid-subclavian bypass and no evidence of endoleak. Conclusion: A trans–ascending aorta through-and-through guidewire is a feasible adjunct that can be added to the endovascular armamentarium when transcardiac or transbrachial approaches are impossible or ineffective.

100 项与 Qasr El Eyni Hospital 相关的药物交易

登录后查看更多信息

100 项与 Qasr El Eyni Hospital 相关的转化医学

登录后查看更多信息